- Report
- December 2024
- 85 Pages
India
From €3234EUR$3,500USD£2,709GBP
- Report
- June 2024
- 90 Pages
United States
From €3234EUR$3,500USD£2,709GBP
- Report
- June 2024
- 132 Pages
North America
From €3696EUR$4,000USD£3,095GBP
- Report
- April 2024
- 185 Pages
Global
From €4158EUR$4,500USD£3,482GBP
- Report
- February 2024
- 188 Pages
Global
From €4158EUR$4,500USD£3,482GBP
- Report
- February 2024
- 182 Pages
Global
From €4158EUR$4,500USD£3,482GBP
- Report
- August 2023
- 73 Pages
Egypt
From €3234EUR$3,500USD£2,709GBP
- Report
- September 2025
- 312 Pages
Global
From €4148EUR$4,490USD£3,475GBP
- Report
- September 2025
- 332 Pages
Global
From €4148EUR$4,490USD£3,475GBP
- Report
- September 2025
- 326 Pages
Global
From €4148EUR$4,490USD£3,475GBP
- Report
- June 2025
- 366 Pages
Global
From €4148EUR$4,490USD£3,475GBP
- Report
- June 2025
- 347 Pages
Global
From €4148EUR$4,490USD£3,475GBP
- Report
- May 2025
- 318 Pages
Global
From €4148EUR$4,490USD£3,475GBP
- Report
- May 2025
- 320 Pages
Global
From €4148EUR$4,490USD£3,475GBP
- Report
- April 2025
- 175 Pages
Global
From €4148EUR$4,490USD£3,475GBP
- Report
- March 2025
- 316 Pages
Global
From €4148EUR$4,490USD£3,475GBP
- Report
- March 2025
- 317 Pages
Global
From €4148EUR$4,490USD£3,475GBP
- Report
- January 2025
- 278 Pages
Global
From €4620EUR$5,000USD£3,869GBP
- Report
- January 2025
- 375 Pages
Global
From €4620EUR$5,000USD£3,869GBP
- Report
- January 2025
- 277 Pages
Global
From €4620EUR$5,000USD£3,869GBP

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more